SLC25A13
Electrogenic aspartate/glutamate antiporter SLC25A13, mitochondrial
Also known as: ARALAR2, CITRIN, CTLN2, S2513_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UJS0
- Gene
- SLC25A13
- Ensembl
- ENSG00000004864
- Chromosome
- 7
- Canonical length
- 675 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters
- Subcellular location
- Mitochondria
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene is a member of the mitochondrial carrier family. The encoded protein contains four EF-hand Ca(2+) binding motifs in the N-terminal domain, and localizes to mitochondria. The protein catalyzes the exchange of aspartate for glutamate and a proton across the inner mitochondrial membrane, and is stimulated by calcium on the external side of the inner mitochondrial membrane. Mutations in this gene result in citrullinemia, type II. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009]
Canonical amino-acid sequenceUniProt
675 residues, UniProt reviewed canonical sequence.
>Q9UJS0|SLC25A13
1 MAAAKVALTK RADPAELRTI FLKYASIEKN GEFFMSPNDF VTRYLNIFGE SQPNPKTVEL
61 LSGVVDQTKD GLISFQEFVA FESVLCAPDA LFMVAFQLFD KAGKGEVTFE DVKQVFGQTT
121 IHQHIPFNWD SEFVQLHFGK ERKRHLTYAE FTQFLLEIQL EHAKQAFVQR DNARTGRVTA
181 IDFRDIMVTI RPHVLTPFVE ECLVAAAGGT TSHQVSFSYF NGFNSLLNNM ELIRKIYSTL
241 AGTRKDVEVT KEEFVLAAQK FGQVTPMEVD ILFQLADLYE PRGRMTLADI ERIAPLEEGT
301 LPFNLAEAQR QKASGDSARP VLLQVAESAY RFGLGSVAGA VGATAVYPID LVKTRMQNQR
361 STGSFVGELM YKNSFDCFKK VLRYEGFFGL YRGLLPQLLG VAPEKAIKLT VNDFVRDKFM
421 HKDGSVPLAA EILAGGCAGG SQVIFTNPLE IVKIRLQVAG EITTGPRVSA LSVVRDLGFF
481 GIYKGAKACF LRDIPFSAIY FPCYAHVKAS FANEDGQVSP GSLLLAGAIA GMPAASLVTP
541 ADVIKTRLQV AARAGQTTYS GVIDCFRKIL REEGPKALWK GAGARVFRSS PQFGVTLLTY
601 ELLQRWFYID FGGVKPMGSE PVPKSRINLP APNPDHVGGY KLAVATFAGI ENKFGLYLPL
661 FKPSVSTSKA IGGGPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC25A13 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 140 nTPM
Expression across tissuesHPA
Tissue
- liver: 140 nTPM
- kidney: 30 nTPM
- spinal cord: 18 nTPM
- retina: 18 nTPM
- rectum: 17 nTPM
- colon: 15 nTPM
Single-cell type
- oligodendrocytes: 485 nCPM
- neutrophils: 470 nCPM
- choroid plexus epithelial cells: 434 nCPM
- retinal pigment epithelial cells: 375 nCPM
- hepatocytes: 366 nCPM
- pituitary stem cells: 274 nCPM
Immune cell
- myeloid DC: 6.1 nTPM
- non-classical monocyte: 5.1 nTPM
- intermediate monocyte: 4.5 nTPM
- classical monocyte: 3.1 nTPM
- plasmacytoid DC: 3.1 nTPM
- memory B-cell: 2.4 nTPM
Brain region
- white matter: 38 nTPM
- choroid plexus: 28 nTPM
- cerebellum: 25 nTPM
- medulla oblongata: 25 nTPM
- basal ganglia: 25 nTPM
- pons: 23 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SLC25A13.
Disease | AllUniProt
Conditions SLC25A13 is implicated in, by any mechanism.
- Citrin deficiency, adolescent or adult onset (CDAA) MIM:603471
- Citrin deficiency, neonatal or infantile onset (CDNI) MIM:605814
Disease | GeneticClinVar
213 pathogenic / likely-pathogenic of 997 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Citrin deficiency
- Citrullinemia, type II, adult-onset
- Citrullinemia
- Neonatal intrahepatic cholestasis due to citrin deficiency
- Citrullinemia type II
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.24
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.3
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- aspartate transmembrane transport
- ATP biosynthetic process
- cellular respiration
- gluconeogenesis
- L-glutamate transmembrane transport
- malate-aspartate shuttle
- mitochondrial transport
- response to calcium ion
Molecular functions
- 3-sulfino-L-alanine: proton, glutamate antiporter activity
- aspartate:glutamate, proton antiporter activity
- calcium ion binding
- identical protein binding
- L-aspartate transmembrane transporter activity
- L-glutamate transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SLC25A13 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC25A13 as an antibody target. Whether an autoantibody or antibody against SLC25A13 could matter depends on whether native SLC25A13 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC25A13 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SLC25A13 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...